Abeona Therapeutics Inc.

Abeona Therapeutics is a U.S. biotechnology company developing and commercializing genetic medicines for serious diseases with significant unmet medical needs. Its capabilities encompass gene therapy and engineered cell therapy approaches, particularly in rare disorders. The company links translational research, clinical development, specialized production and patient access work to support advanced therapies. Abeona's common stock is listed on Nasdaq under ABEO. Genetic and cellular interventions are central to its technology strategy, distinguishing its drug-development business from diagnostic testing and contract research services. Such treatments require dedicated processes for product characterization, manufacturing, clinical evaluation and patient delivery.